Onclive Team

A report issued by the Council for Affordable Quality Healthcare (CAQH) suggests that if providers and health plans converted fully from manual to electronic transactions, it could result in an additional estimated savings of $8.1 billion for the healthcare industry.

Medicaid patients in states that pay more for office visits had an increased likelihood of being screened for cancer, according to results of a study published in CANCER.

How much physicians get paid is increasingly determined by a payment formula that penalizes doctors whose patients are more expensive-even when those higher costs stem from services that other doctors perform says a new report from the Center for Healthcare Quality and Payment Reform.

Although the Affordable Care Act (ACA) made accessibility to health insurance easier, consumers are finding themselves shouldering greater out-of-pocket costs in the form of copayments and deductibles for the care that they receive. Physicians are also feeling the need to collect more fees from more of their patients.

Starting in January 2015, Medicare will begin paying physicians for the care coordination they provide beneficiaries with chronic conditions.

Patients with Medicaid insurance and those without insurance were more likely to present with distant disease than patients with private insurance, according to results presented in the Journal of Clinical Oncology.

Settlemen addressed broad questions about his research into acquired resistance mechanisms in an interview with OncologyLive.

A multipractice oncology medical home model, the Michigan Oncology Medical Home Demonstration Project (MOMHDP), reported preliminary first-year results that tallied an estimated savings per patient of $550.33, according to an abstract in the Journal of Oncology Practice.

A Florida accountable care organization (ACO) is reporting $22 million in savings during its first year, with a shared savings of $11 million.

The Centers for Medicare & Medicaid Services (CMS) took down its Web site that verifies payments from pharmaceutical companies to physicians, after at least 1 doctor had payments attributed to him that were actually made to someone else.

Co-management agreements between hospitals and medical practices can be mutually beneficial to both parties, but proper execution is required to realize the benefits.

A regional bundled payment system has hit a roadblock in California, according to a study in Health Affairs. The program failed to meet its goals, succumbed to recruitment challenges, faced regulatory uncertainty, and sputtered under administrative burdens.

The US Department of Health and Human Services has finalized Oct. 1, 2015, as the new compliance date for providers and payers to transition to ICD-10.

A new health policy brief issued by Health Affairs and the Robert Wood Johnson Foundation explains the origin of these differential payments and the debate over approaches that have been proposed for developing so called "site neutral" payments.

Having financial counselors on staff is becoming a new reality for oncology practices as patients are responsible for out-of-pocket costs and more are participating in health insurance exchanges, says an article in Healthcare Finance News.

It looks like e-prescribing through the use of electronic health records (EHRs) is here to stay according to findings from the July 2014 "ONC Data Brief," issued by The Office of the National Coordinator for Health Information Technology.

Many specialists are balking at what they say are onerous new rules to get recertified, warning the demands will force some physicians out of practice at a time when the nation faces a shortage.

Joseph Flynn, DO, MPH, focuses on the development of novel therapeutics for the treatment of chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL) in his research at The Ohio State University Comprehensive Cancer Center.

As the use of electronic patient portals grows, a new study examines the use of these portals by cancer patients, extending the doctor-patient relationship to new boundaries.

Leading experts from renowned academic centers join in one voice to encourage new perspectives in addressing brain cancer

Surgical Team at NYU Langone Medical Center Successfully Removes Life-Threatening Retroperitoneal Mass Along with Several Organs -- Staten Island Resident Expresses His Thanks

A pilot program that paid oncologists upfront for the patient's full treatment program regardless of the drugs administered resulted in a 34% reduction in medical costs.

Every patient with a rare but aggressive form of ovarian cancer had tumors with the same type of mutations, suggesting a causative role for the mutations.

A treatment intended to control chemotherapy-induced nausea and vomiting that combines netupitant and palonosetron demonstrated superior activity in complete response rates over oral palonosetron monotherapy.

Genetic testing limited to BRCA1/2 mutations would have missed 29% of mutations that carry hereditary risk of ovarian cancer, a study using next-generation sequencing showed.

One-quarter of patients with relapsed or refractory BRCA-mutant ovarian cancer attained major objective responses to treatment with the investigational PARP inhibitor veliparib.

Premier Awards Program Recently Named 2014 Giants Class; Event to Honors New York Area Physicians

Gad Getz, PhD, MSc, focuses on cancer genome analysis, particularly cataloging all of the genomic events that occur during the development of cancer, in his laboratory at the Broad Institute at MIT and Harvard.

Einhorn, now a distinguished professor and Livestrong Foundation Professor of Oncology at the IU School of Medicine, has driven other major advances in the treatment of testicular cancer, coming up with a more effective and less toxic standard regimen and revealing important principles that are being applied to the treatment of other cancer types.

Cutting-edge translational research pioneer will work with OncLive to promote knowledge of genetic research and its application to patient care.